Pulmonx (LUNG)
(Delayed Data from NSDQ)
$1.61 USD
-0.23 (-12.50%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.66 +0.05 (3.11%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Pulmonx Corporation has a market cap of $74.07M, which represents its share price of $1.84 multiplied by its outstanding shares number of 40.26M. As a small-cap company, LUNG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LUNG 1.61 -0.23(-12.50%)
Will LUNG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LUNG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LUNG
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
LUNG: What are Zacks experts saying now?
Zacks Private Portfolio Services
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
Other News for LUNG
Pulmonx (LUNG) Analyst Ratings Update: Wells Fargo Lowers Price Target | LUNG Stock News
Crude Oil Falls 1%; Meta Earnings Top Views
12 Health Care Stocks Moving In Thursday's Intraday Session
Stifel Lowers Pulmonx (LUNG) Price Target to $5.00, Maintains Buy Rating | LUNG Stock News
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings